AGREEMENT AND PLAN OF MERGER among: VALLON PHARMACEUTICALS, INC.; VALLON MERGER SUB, INC.; and GRI BIO, INC. Dated as of December 13, 2022Agreement and Plan of Merger • December 13th, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 13th, 2022 Company Industry JurisdictionThis Agreement and Plan of Merger (this “Agreement”) is made and entered into as of December 13, 2022, by and among VALLON PHARMACEUTICALS, INC., a Delaware corporation (“PubCo”), VALLON MERGER SUB, INC., a Delaware corporation and wholly owned Subsidiary of PubCo (“Merger Sub”), and GRI BIO, INC., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1.
AGREEMENT AND PLAN OF MERGER among: SENECA BIOPHARMA INC.; TOWNSGATE ACQUISITION SUB 1, INC.; and LEADING BIOSCIENCES, INC. Dated as of December 16, 2020Agreement and Plan of Merger • December 21st, 2020 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledDecember 21st, 2020 Company Industry JurisdictionThis Agreement and Plan of Merger (this “Agreement”) is made and entered into as of December 16, 2020, by and among Seneca Biopharma, Inc., a Delaware corporation (“PubCo”), Townsgate Acquisition Sub 1, Inc., a Delaware corporation and wholly owned Subsidiary of PubCo (“Merger Sub”), and Leading BioSciences, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1.